Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novo Nordisk describes heterocyclic compounds for neurogenic pain/inflammation

May 8, 1997

ECE inhibitors from Santen

May 8, 1997

FDA clears generic antidepressant from Teva

May 7, 1997

Alniditan more effective than sumatriptan in animal model of migraine

May 7, 1997

Riboflavin shows promise for migraine prophylaxis

May 7, 1997

Population-based study of postmenopausal ERT and risk of AD

May 7, 1997

Rotterdam study assesses risk factors for dementia and AD

May 7, 1997

Warner-Lambert reveals agents with dual dopaminergic/serotonergic activity

May 7, 1997

nAChR ligands prepared by Novo Nordisk

May 7, 1997

Kyowa Hakko claims analgesic agents

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...